These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 36834614)

  • 1. Antiphospholipid Syndrome in Pregnancy: New and Old Pathogenetic Mechanisms.
    D'Ippolito S; Barbaro G; Paciullo C; Tersigni C; Scambia G; Di Simone N
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Obstetric Antiphospholipid Syndrome: Insights on the Diagnosis, Treatment, and Hot Issues].
    Gao R; Qin L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 May; 55(3):513-520. PubMed ID: 38948301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy.
    Mayer-Pickel K; Eberhard K; Lang U; Cervar-Zivkovic M
    Clin Rev Allergy Immunol; 2017 Aug; 53(1):54-67. PubMed ID: 27395067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome.
    Anunciación-Llunell A; Muñoz C; Roggenbuck D; Frasca S; Pardos-Gea J; Esteve-Valverde E; Alijotas-Reig J; Miró-Mur F
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of obstetric antiphospholipid syndrome (OAPS) and non-criteria obstetric APS (NC-OAPS): report of 1640 cases from the EUROAPS registry.
    Alijotas-Reig J; Esteve-Valverde E; Ferrer-Oliveras R; Sáez-Comet L; Lefkou E; Mekinian A; Belizna C; Ruffatti A; Hoxha A; Tincani A; Nalli C; Marozio L; Maina A; Espinosa G; Ríos-Garcés R; Cervera R; Carolis S; Monteleone G; Latino O; Udry S; LLurba E; Garrido-Gimenez C; Trespidi L; Gerosa M; Chighizola CB; Rovere-Querini P; Canti V; Mayer-Pickel K; Tabacco S; Arnau A; Trapé J; Ruiz-Hidalgo D; Sos L; Farran-Codina I;
    Rheumatology (Oxford); 2020 Jun; 59(6):1306-1314. PubMed ID: 31580459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-annexin A5 antibodies and 25-hydroxy-cholecalciferol in female patients with primary antiphospholipid syndrome.
    Bećarević M; Sarić M; Stojanovich L; Mirković D; Dopsaj V; Ignjatović S
    Clin Rheumatol; 2018 Dec; 37(12):3359-3364. PubMed ID: 29948348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between endothelial cell-derived extracellular vesicles and monocytes: A potential link between vascular thrombosis and pregnancy-related morbidity in antiphospholipid syndrome.
    Álvarez D; Morales-Prieto DM; Cadavid ÁP
    Autoimmun Rev; 2023 Apr; 22(4):103274. PubMed ID: 36649876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trophoblast Cell Function in the Antiphospholipid Syndrome.
    Vrzić Petronijević S; Vilotić A; Bojić-Trbojević Ž; Kostić S; Petronijević M; Vićovac L; Jovanović Krivokuća M
    Biomedicines; 2023 Sep; 11(10):. PubMed ID: 37893055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing antiphospholipid syndrome in pregnancy.
    Schreiber K; Hunt BJ
    Thromb Res; 2019 Sep; 181 Suppl 1():S41-S46. PubMed ID: 31477227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An advanced understanding of the heterogeneous clinical features of "non-criteria" obstetric antiphospholipid syndrome: Two case reports and a literature review.
    Peng X; Tan X; Xing A
    Front Immunol; 2023; 14():1122127. PubMed ID: 36865564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathogenesis of obstetric APS: a 2023 update.
    Mineo C; Shaul PW; Bermas BL
    Clin Immunol; 2023 Oct; 255():109745. PubMed ID: 37625670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid syndrome pathogenesis in 2023: an update of new mechanisms or just a reconsideration of the old ones?
    Raschi E; Borghi MO; Tedesco F; Meroni PL
    Rheumatology (Oxford); 2024 Feb; 63(SI):SI4-SI13. PubMed ID: 38320591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic role of anti-beta2-glycoprotein I antibodies on human placenta: functional effects related to implantation and roles of heparin.
    Di Simone N; Meroni PL; D'Asta M; Di Nicuolo F; D'Alessio MC; Caruso A
    Hum Reprod Update; 2007; 13(2):189-96. PubMed ID: 17099207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first thrombotic event in purely obstetric antiphospholipid syndrome patients and in antiphospholipid antibody carriers: comparison of incidence and characteristics.
    Tonello M; Calligaro A; Favaro M; Del Ross T; Veronese P; Salvan E; Gervasi MT; Ruffatti A
    Arch Gynecol Obstet; 2021 Feb; 303(2):455-461. PubMed ID: 32880711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome.
    Forastiero R; Martinuzzo M
    Expert Rev Clin Immunol; 2015; 11(11):1255-63. PubMed ID: 26295486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection by hydroxychloroquine prevents placental injury in obstetric antiphospholipid syndrome.
    Liu J; Zhang L; Tian Y; Wan S; Hu M; Song S; Zhang M; Zhou Q; Xia Y; Wang X
    J Cell Mol Med; 2022 Aug; 26(15):4357-4370. PubMed ID: 35770338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antiphospholipid syndrome: from pathophysiology to treatment.
    Negrini S; Pappalardo F; Murdaca G; Indiveri F; Puppo F
    Clin Exp Med; 2017 Aug; 17(3):257-267. PubMed ID: 27334977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of anti-beta 2-glycoprotein 1 antibodies and its association with pregnancy-related morbidity in antiphospholipid syndrome.
    Fierro JJ; Velásquez M; Cadavid AP; de Leeuw K
    Am J Reprod Immunol; 2022 Jan; 87(1):e13509. PubMed ID: 34738282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is There an Additional Value in Detecting Anticardiolipin and Anti-β2 glycoprotein I IgA Antibodies in the Antiphospholipid Syndrome?
    Chayoua W; Yin DM; Kelchtermans H; Moore GW; Gris JC; Musiał J; Zuily S; Ten Cate H; de Laat B; Devreese KMJ
    Thromb Haemost; 2020 Nov; 120(11):1557-1568. PubMed ID: 32696448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.